What is the recommended dose of fluconazole (antifungal medication) for various fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole Dosing for Fungal Infections

For most systemic Candida infections (candidemia), initiate fluconazole with a loading dose of 800 mg (12 mg/kg) on day 1, followed by 400 mg (6 mg/kg) daily maintenance dosing, continuing for 2 weeks after the first negative blood culture and resolution of symptoms. 1, 2, 3

Systemic Candida Infections (Candidemia and Invasive Candidiasis)

  • Loading dose: 800 mg (12 mg/kg) on day 1, then 400 mg (6 mg/kg) daily for candidemia and disseminated candidiasis 1, 2, 4
  • Continue treatment for 2 weeks after documented clearance from bloodstream and symptom resolution 1, 2
  • For neutropenic patients, extend therapy for 2 weeks after neutropenia resolves (neutrophil count >1000 cells/mm³) 1
  • Central venous catheter removal is strongly recommended for all patients with candidemia 1, 4

Critical Species-Specific Considerations:

  • Fluconazole has NO activity against Candida krusei and variable activity against C. glabrata—confirm susceptibility before use 1, 2, 4
  • For C. parapsilosis, fluconazole is appropriate; if echinocandin used initially, consider switching to fluconazole 5
  • For C. glabrata, only use fluconazole after confirming susceptibility with negative follow-up cultures 5
  • For C. krusei, use echinocandins or amphotericin B instead 5

Oropharyngeal and Esophageal Candidiasis

Oropharyngeal:

  • Loading dose: 200 mg on day 1, then 100 mg once daily for 7-14 days 1, 2, 4
  • For moderate to severe disease, increase to 100-200 mg daily 2
  • Topical agents are preferred first-line for mild disease 2

Esophageal:

  • 200-400 mg daily for 14-21 days until clinical improvement 5, 2
  • Treat for minimum 3 weeks and at least 2 weeks following symptom resolution 2, 3
  • Doses up to 400 mg/day may be used based on clinical response 3

Urinary Tract Infections

Symptomatic Cystitis:

  • 200 mg (3 mg/kg) daily for 14 days 5, 1, 2, 4

Pyelonephritis:

  • 200-400 mg (3-6 mg/kg) daily for 14 days 5, 1, 2, 4
  • For patients with suspected disseminated candidiasis, treat as candidemia 5

Asymptomatic Candiduria:

  • Therapy not usually needed 5
  • For high-risk surgical patients, neonates, or neutropenic patients, treat as disseminated candidiasis 5

CNS Candidiasis

  • 400-800 mg (6-12 mg/kg) daily for patients unable to tolerate amphotericin B 5, 1, 2, 4
  • Amphotericin B with or without flucytosine is preferred; fluconazole is reserved for intolerant patients 5, 1
  • Remove intraventricular devices 5
  • Continue until all signs, symptoms, CSF abnormalities, and radiologic findings resolve 5

Chronic Disseminated Candidiasis

  • 400 mg (6 mg/kg) daily for stable patients 1, 2, 4
  • Continue until lesions resolve on imaging, typically 3-6 months 5, 4
  • Transition from amphotericin B to fluconazole after several weeks in stable patients 5, 4

Vulvovaginal Candidiasis

  • Single dose of 150 mg orally 1, 3, 6
  • Clinical cure rate of 88% at long-term follow-up (27-62 days) 6

Candida Endophthalmitis

  • Fluconazole is an alternative option (specific dose not standardized in guidelines) 5
  • Duration at least 4-6 weeks, determined by repeated examinations 5
  • Surgical intervention required for severe endophthalmitis or vitreitis 5

Candida Osteoarticular Infections

  • 400 mg (6 mg/kg) daily for 6-12 months for osteomyelitis 1
  • Surgical debridement frequently necessary 1

Cryptococcal Meningitis

Acute Treatment:

  • 400 mg on day 1, then 200 mg once daily 3
  • May increase to 400 mg once daily based on clinical response 3
  • Treat for 10-12 weeks after CSF becomes culture negative 3

Maintenance/Suppression in AIDS:

  • 200 mg once daily to prevent relapse 3

Prophylaxis in Bone Marrow Transplant

  • 400 mg once daily 1, 3
  • Start several days before anticipated neutropenia onset 3
  • Continue for 7 days after neutrophil count rises above 1000 cells/mm³ 3

Pediatric Dosing Conversion

  • 3 mg/kg ≈ 100 mg adult dose 1, 4
  • 6 mg/kg ≈ 200 mg adult dose 1, 4
  • 12 mg/kg ≈ 400 mg adult dose 1, 4
  • Some older children may have clearances similar to adults; absolute doses exceeding 600 mg/day are not recommended 3

Neonatal Candidiasis

  • Amphotericin B 1.0 mg/kg/day OR fluconazole 12 mg/kg/day OR echinocandin 5
  • Lumbar puncture and ophthalmoscopic examination recommended 5
  • For candidemia without persistent fungemia or metastatic complications, treat for 3 weeks 5

Critical Pitfalls to Avoid

  • Inadequate treatment duration leads to relapse—continue until clinical and laboratory parameters indicate resolution 1, 4
  • Relapse rates are high (40%) in immunocompromised patients, particularly those with AIDS 7, 8
  • Candida isolated from respiratory secretions usually represents colonization, not infection—rarely requires treatment 2
  • For fluconazole-resistant species, use alternative antifungals (echinocandins, amphotericin B, voriconazole) 1, 4
  • Maximum daily dose of 1600 mg recommended to avoid neurological toxicity 7
  • Hypochlorhydria, food intake, and gastrointestinal resection do not affect fluconazole absorption 7

References

Guideline

Fluconazole Dosing for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluconazole Dosing Guidelines for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluconazole Dosing Guidelines for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.